Diasorin S.P.A. operates within the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Diasorin S.P.A. with three other
pharmaceutical manufacturers in Europe:
sales of 614.49 million Euro [US$722.93 million]
of which 51%
was Non-Proprietary Homeopathic Medicines),
Siegfried Holding AG
(717.73 million Swiss Francs [US$723.51 million]
of which 78%
was Drug Substances), and
based in Germany
(553.10 million Euro [US$650.71 million]
of which 63%
During the year ended December of 2016, sales at
Diasorin S.P.A. were 569.31 million Euro (US$669.78 million).
increase of 14.0%
versus 2015, when the company's sales were 499.18 million Euro.
This was the fourth straight year of sales growth at Diasorin S.P.A..